INTRODUCTION Ψ
Amodiaquine plus artesunate combination popularly sold as Larimal ® , is a combination of amodiaquine (AQ) 153.1mg, and artesunate (AS) 50mg, and has been increasingly used in the treatment of uncomplicated malaria caused by Plasmodium falciparum. The action of this drug is seen in its constituting drugs, AQ and AS 1 . AQ is a 4-aminoquinoline antimalarial drug with schizonticidal activity and a similar mode of action to chloroquine. It also possesses antipyretic and anti-inflammatory properties and is effective against the erythrocytic stages of all Ψ Correspondence at: egwuoc@yahoo.com four species of Plasmodium falciparum 1, 2 . The mode of AQ action is immune mediated 3 . This has earlier been reported 4 , where AQ gave rise to chemically reactive species by at least three distinct mechanisms, viz. autoxidation in neutral solution under air, peroxidase-catalyzed oxidation and N-chlorination. In therapeutic doses used for prophylaxis and for malaria therapy, AQ has been reported to occasionally cause peripheral neuropathy, and vertigo and lethargy occasionally 1 . Large doses of AQ have been reported to cause syncope, spasticity, convulsion and involuntary movements. The usual sign and symptoms of an overdose are headache, vertigo and vomiting 1 . Artesunate on the other hand is a water-soluble hemisuccinate derivative of artemisinin. It is made of endoperoxide bond, which is the functional group responsible for the antimalarial activity of AS 1 . The mechanism of action involves the heme-mediated decomposition of the endoperoxide bond to produce carboncentered free radicals. Release of these active oxygen species from this bond kills the parasite if accumulated in the erythrocytes 5 . Neurotoxicity has been observed in animal studies but not in humans 6 . Other possible effects include; dizziness, headache, body ache, tinnitus and convulsions with cardiotoxicity observed in high doses 1 . In animal studies, neurologic defects such as gait disturbances, loss of spinal and pain reflexes 7 , prominent loss of brain stem and eye reflexes and prominent neuropathic lesions sharply limited to the brain stem 7-9 , ataxia and slurred speech 10 have been reported with artesunate. With these facts in mind, this work was carried out to determine the possible effect of amodiaquine in combination with artesunate on the histology of the cerebellum of Wistar rats.
MATERIALS AND METHODS
Twenty adult Wistar rats weighing between 150-180g were divided into four groups (A, B, C and D) of five animals each. Each packet of Larimal ® contained twelve blister tablets each of AQ Hydrochloride USP equivalent to AQ base (153.1mg) and AS (50mg). The drugs were given orally using orogastric tubes. The dosages were in milligram per kilogram body weight (mg/kg) given twelve hourly (twice a day) using distilled water as the vehicle. The treatment lasted three days for groups B and D, and six days for group C animals. Group A served as the control and the animals received distilled water. These are seen in Table 1 . Larimal ® = amodiaquine plus artesunate Twelve hours after the last administrations the animals were sacrificed by chloroform anaesthesia. There were perfused with formal saline and the skulls opened to remove the cerebellums. Routine Haematoxylin and eosin method 11 was used for processing the tissues. (Figure 4) 
RESULTS

Group
DISCUSSION
There were slight lesions in group B treated with 8.75+2.86mg/kg of amodiaquine plus artesunate for three days, and reduction in the Purkinje cells sizes and population, as well as shrinkage of this layer in groups C and D sections treated with 8.75+2.86mg/kg and 17.50+5.71mg/kg respectively of amodiaquine plus artesunate for six and three days compared to the control. Amodiaquine (AQ) and artesunate (AS) are the components of Larimal ® , and have some adverse effects on the brain tissues of the body. AQ is a 4-aminoquinolone, which generates free radicals in the form of AQ quinone immine and semi quinone immine. These have been implicated in lipid peroxidation in the membranes of hepatocyte cells 4 . It does not require an overdose for its toxicity, because it is still toxic to mammalian cells in therapeutic dose 1 . Artemisinin and its derivatives are toxic to malaria parasites in vitro at nanomolar concentration, whereas micromolar concentration is required for toxicity to mammalian cells 11 . AS releases reactive, alkylating, oxygen free radicals from its endoperoxide bond 4 leading to lipid peroxidation 12 . The effects seen in this study might have been due to the ability of the components of the drug to carry out the above effects in the cerebellum of the treated Wistar rats. There have been reports that chemically induced neurodegeneration is usually characterised by different patterns of neuronal cell death, gliosis, swollen or destroyed axons, or destruction of the myelin sheath. These effects are usually preceded by changes on biochemical targets 13 . This is in line with the study 14 who reported that Wistar rats treated with Cyclophosphamide or Lomustine showed changes in the cerebellum with ultrastructural lesions found mainly in the astroglia cells localized in the perivascular area. The cytoplasm of these cells was on the large area devoid of organelles. Neurons were less affected but in Purkinje cells, mild ultrastructural lesions were found with increased activity of glucose-6-phosphatase and decreased succinate dehydrogenase activity, suggesting disturbed metabolism in the neurons. The change in the cell morphology at light microscopic level as seen in this study, shows that the drug affects the Purkinje cells and layer in the groups treated with 8.75+2.86mg/kg and 17.50+5.71mg/kg of amodiaquine plus artesunate for six and three days respectively. This may result in inadequate output signal from the cerebellar cortex to the rest of the brain and other parts of the body, since it is the major cortical output of the cerebellum. The cerebellum functions in the maintenance of balance and coordination of all motor activities 15 . With the disruption of output signals, it may result in the inability of the cerebellum to function effectively. These results reveal that amodiaquine plus artesunate causes histological alterations in the cerebellum, which may result in cerebellar dysfunction manifesting in some motor problems like dizziness, gait disturbances and convulsion; and these effects were dose and time dependent.
